Bottom line
JIRE vs NBIIX: the short answer
JIRE (JPMorgan International Research Enhanced Equity ETF) and NBIIX (Neuberger International Equity Fund) are quite different portfolios: only about 32% of their top holdings (by weight) are shared.
But JIRE is far broader, holding 214 positions to 93 for NBIIX, so beyond the top names it adds exposure NBIIX doesn't have.
JIRE is cheaper at 0.24% vs 0.85% — a difference of $61 a year per $10,000 invested.
Over five years, JIRE returned +9.7% a year vs +4.0% for NBIIX (reporting dates differ).
Updated Nov 19, 2026
JIRE vs NBIIX side by side
| JIRE | NBIIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | Neuberger Berman Equity |
| Category | International Stock | International Stock |
| Expense ratio | 0.24% | 0.85% |
| Annual cost per $10k | $24 | $85 |
| 10-yr cost on $10k (prospectus) | $363 | $1,208 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +32.1% | +5.4% |
| 5-yr return (annualized) | +9.7% | +4.0% |
| 10-yr return (annualized) | +8.2% | +5.3% |
| Best quarter | +17.8% | +21.3% |
| Worst quarter | −23.4% | −23.4% |
| Net assets (fund) | $11.2B | $1.1B |
| Number of holdings | 214 | 93 |
| Portfolio turnover | 25% | 61% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JIRE | NBIIX | Difference |
|---|---|---|---|
| 2024 | +3.0% | +5.4% | −2.4% |
| 2023 | +19.7% | +14.3% | +5.4% |
| 2022 | −13.7% | −22.0% | +8.3% |
| 2021 | +12.9% | +13.6% | −0.7% |
| 2020 | +5.4% | +13.9% | −8.5% |
| 2019 | +22.0% | +27.9% | −5.9% |
| 2018 | −14.7% | −16.4% | +1.8% |
| 2017 | +23.3% | +27.2% | −3.9% |
| 2016 | +2.1% | −1.1% | +3.1% |
Source: Fund prospectus bar charts
Holdings overlap
7 of JIRE's top 25 holdings also appear in NBIIX's top 25.
| Holding | JIRE | NBIIX |
|---|---|---|
| ASML Holding NV | 3.48% | 2.67% |
| Siemens AG | 1.78% | 1.71% |
| AstraZeneca plc | 1.69% | 1.93% |
| Shell plc | 1.55% | 2.57% |
| Banco Santander SA | 1.36% | 1.84% |
| UniCredit SpA | 1.33% | 1.85% |
| Roche Holding AG | 1.32% | 1.97% |
Source: SEC Form N-PORT
JIRE top 10
- ASML Holding NV — 3.48%
- Siemens AG — 1.78%
- AstraZeneca plc — 1.69%
- Shell plc — 1.55%
- HSBC Holdings plc — 1.54%
- Allianz SE — 1.51%
- Banco Santander SA — 1.36%
- UniCredit SpA — 1.33%
- Nestle SA — 1.33%
- Roche Holding AG — 1.32%
NBIIX top 10
- British American Tobacco PLC — 2.80%
- ASML Holding NV — 2.67%
- Shell PLC — 2.57%
- Anheuser-Busch InBev SA/NV — 2.21%
- Roche Holding AG — 1.97%
- AstraZeneca PLC — 1.93%
- UniCredit SpA — 1.85%
- Banco Santander SA — 1.84%
- ASM International NV — 1.81%
- Rwe Ag — 1.77%
FAQ
What is the difference between JIRE and NBIIX?
Which is cheaper, JIRE or NBIIX?
Should I own both JIRE and NBIIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.